Drug
Obeticholic Acid
Obeticholic Acid: highest development phase Post-Market, developed by Intercept Pharmaceuticals, United Therapeutics. 13 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Intercept Pharmaceuticals, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Obeticholic Acid (OCA) NCT03633227 | Post-Market | Liver Cirrhosis, Biliary |
| Obeticholic Acid (OCA) NCT02308111 | Post-Market | Liver Cirrhosis, Biliary |
| Obeticholic Acid (OCA) NCT01473524 | Phase 3 | Primary Biliary Cirrhosis |
| Obeticholic acid (10 mg) NCT03439254 | Phase 3 | Compensated Cirrhosis |
| Obeticholic Acid NCT02548351 | Phase 3 | Non Alcoholic Steatohepatitis (NASH) |
| Obeticholic Acid (OCA) NCT00570765 | Phase 2 | Liver Cirrhosis, Biliary |
| Obeticholic Acid NCT01865812 | Phase 2 | Primary Biliary Cirrhosis |
| Obeticholic Acid NCT02633956 | Phase 2 | Nonalcoholic Steatohepatitis |
| Obeticholic acid NCT04594694 | Phase 2 | Primary Biliary Cholangitis |
| Obeticholic Acid (OCA) NCT02177136 | Phase 2 | Primary Sclerosing Cholangitis (PSC) |
| 10 mg Obeticholic Acid (OCA) NCT02039219 | Phase 2 | Alcoholic Hepatitis |
| obeticholic acid 10 mg NCT01904539 | Phase 1 | Hepatic Impairment |
| 10 mg Obeticholic Acid (OCA) NCT02654236 | Not Applicable | Alcohol Consumption |
Latest
No recent events.
Follow Obeticholic Acid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.